Compensated Leydig cell failure (increased LH with low normal testosterone levels or exaggerated FSH and LH responses to LH-releasing hormone) and gynaecomastia have been reported in patients treated with a combination of mustine and procarbazine and after treatment with high-dose cyclophosphamide (49, 67, 68). This evidence concerns the gene PLOD1 and Gynecomastia.